---
title: "Research Overview: ARA 290"
subtitle: "A comprehensive laboratory research guide to ARA 290, a synthetic nonapeptide derived from erythropoietin for tissue protection, neuroprotection, anti-inflammatory mechanisms, and peripheral neuropathy research"
author: "Vici Peptides Editorial"
publishedDate: "2025-01-XX"
category: "Repair / Healing / Anti-inflammatory"
keywords: ["ARA 290", "ARA290", "Erythropoietin-derived peptide", "EPO nonapeptide", "erythropoietin fragment", "tissue protection", "neuroprotection", "anti-inflammatory", "peripheral neuropathy", "tissue repair", "inflammatory responses", "EPO receptor", "tissue protection peptide", "neuroprotective peptide", "research peptide", "laboratory research", "mechanism of action", "chemical formula", "C44H68N12O12", "tissue protection research", "neuroprotection mechanisms", "anti-inflammatory mechanisms", "peripheral nerve protection", "tissue repair mechanisms", "inflammatory pathway modulation", "cytokine modulation", "nerve regeneration", "tissue cytoprotection"]
relatedProductSlug: "ara-290-10mg"
---

import { ArticleImage } from '@/components/blog/ArticleImage';

# Research Overview: ARA 290

> A comprehensive laboratory research guide to ARA 290, a synthetic nonapeptide derived from erythropoietin for tissue protection, neuroprotection, anti-inflammatory mechanisms, and peripheral neuropathy research

## Table of Contents

- [Introduction](#introduction)
- [Mechanism of Action](#mechanism-of-action)
- [Chemical Background](#chemical-background)
- [Laboratory Applications](#laboratory-applications)
- [Handling and Storage Guidelines](#handling-storage)

## Introduction

ARA 290, also commonly referred to as ARA290 in research communities, represents a synthetic nonapeptide derived from erythropoietin (EPO) that has been studied for its potential tissue protection and anti-inflammatory effects without the hematopoietic activity of the full EPO molecule. Laboratory researchers utilize ARA 290 (ARA290) to investigate tissue protection, neuroprotection, anti-inflammatory mechanisms, peripheral neuropathy, and tissue repair processes in experimental models. The compound falls within the Repair / Healing / Anti-inflammatory category and serves as a valuable research tool for understanding EPO-derived peptide mechanisms and tissue protection pathways.

ARA 290 (ARA290) is used in laboratory research to investigate tissue protection and anti-inflammatory mechanisms. Research applications include studies on neuroprotection, tissue repair, inflammatory responses, peripheral neuropathy, and tissue protection pathways in experimental models. The compound has been investigated for its potential role in protecting tissues from various forms of injury, providing neuroprotective effects, reducing inflammation, and supporting tissue repair processes. These investigations contribute to the broader understanding of tissue protection mechanisms and may inform future research directions in neuroprotection, tissue repair, and anti-inflammatory research.

The nonapeptide has been studied extensively in laboratory settings for its potential effects on nervous system tissues, peripheral nerves, and various other tissue types. Researchers investigate ARA 290 (ARA290) to understand how this EPO-derived peptide may influence tissue protection, neuroprotection, anti-inflammatory processes, and tissue repair mechanisms. These studies contribute to understanding EPO receptor signaling and may provide insights into tissue protection and neuroprotection research applications.

## Mechanism of Action

ARA 290 (ARA290) functions through multiple interconnected mechanisms that contribute to its research applications in tissue protection and anti-inflammatory processes. The compound's mechanism of action involves interactions with EPO receptors, tissue protection pathways, neuroprotective mechanisms, and anti-inflammatory signaling. Understanding these mechanisms is essential for laboratory researchers investigating tissue protection and neuroprotection pathways.

One of the primary mechanisms involves EPO receptor activation, specifically the tissue-protective EPO receptor complex. ARA 290 (ARA290) has been shown in laboratory studies to activate EPO receptors that are distinct from those involved in erythropoiesis, allowing for tissue protection effects without hematopoietic activity. The compound binds to a heteromeric receptor complex consisting of EPO receptor and beta common receptor (βcR), which mediates tissue-protective effects. This mechanism is particularly relevant for research into tissue protection, neuroprotection, and tissue repair without the side effects associated with full EPO activity.

The compound also influences neuroprotective mechanisms, particularly in peripheral nervous system tissues. ARA 290 (ARA290) has been studied for its potential to protect nervous system tissues from various forms of injury, including peripheral neuropathy, nerve damage, and neurotoxic insults. Laboratory studies have investigated how the compound may influence neuronal survival, nerve regeneration, and nervous system function. These effects are particularly relevant for research into peripheral neuropathy, nerve protection, and neuroregeneration.

Anti-inflammatory effects represent another important mechanism of action. ARA 290 (ARA290) has been shown to reduce inflammation through effects on cytokine production, inflammatory signaling pathways, and immune cell function. The compound may reduce pro-inflammatory cytokines while potentially promoting anti-inflammatory mediators. This mechanism is relevant for research into inflammatory conditions, tissue repair in inflammatory environments, and inflammation control.

Tissue protection mechanisms involve effects on cellular survival and tissue integrity. ARA 290 (ARA290) has been investigated for its potential to protect various tissue types from injury, including ischemic injury, oxidative stress, and other forms of tissue damage. Laboratory studies have explored how the compound may enhance cellular survival, reduce tissue damage, and support tissue repair processes. These effects make ARA 290 (ARA290) valuable for research into tissue protection and cytoprotection.

Peripheral neuropathy research represents another important area of investigation. ARA 290 (ARA290) has been studied for its potential effects on peripheral nerve function and neuropathy. Laboratory research has investigated how the compound may protect peripheral nerves, support nerve regeneration, and improve nerve function in experimental models of peripheral neuropathy. These effects make ARA 290 (ARA290) valuable for research into peripheral neuropathy and nerve protection.

The stability of ARA 290 (ARA290) (shelf life: 36 months) is an important consideration for laboratory research. Proper storage and handling are essential to maintain the compound's biological activity and structural integrity throughout experimental procedures. Researchers typically assess the compound's stability under various conditions, including temperature, pH, and storage duration, to ensure reliable experimental results.

Laboratory researchers investigate several specific mechanisms through which ARA 290 (ARA290) may influence tissue protection and anti-inflammatory processes:

- **EPO receptor activation**: The compound activates tissue-protective EPO receptor complexes without hematopoietic effects
- **Neuroprotective effects**: ARA 290 (ARA290) may protect nervous system tissues from injury and support nerve function
- **Peripheral nerve protection**: The compound may protect peripheral nerves and support nerve regeneration
- **Anti-inflammatory mechanisms**: ARA 290 (ARA290) may reduce inflammation through effects on cytokines and inflammatory pathways
- **Tissue cytoprotection**: The compound may protect various tissue types from injury and damage
- **Cellular survival enhancement**: ARA 290 (ARA290) may promote cellular survival and reduce cell death
- **Tissue repair support**: The compound may support tissue repair processes and recovery
- **Oxidative stress protection**: ARA 290 (ARA290) may protect tissues from oxidative damage
- **Inflammatory pathway modulation**: The compound may modulate inflammatory signaling pathways
- **Cytokine modulation**: ARA 290 (ARA290) may influence pro-inflammatory and anti-inflammatory cytokine production

The biological function of ARA 290 (ARA290) in research contexts involves its interaction with cellular targets related to tissue protection, neuroprotection, and anti-inflammatory processes. Laboratory studies have investigated the compound's effects on tissue protection, neuroprotection, anti-inflammatory mechanisms, peripheral neuropathy, and tissue repair. Understanding these interactions helps researchers design experiments to investigate specific biological processes and pathways related to tissue protection, neuroprotection, and anti-inflammatory mechanisms.

## Chemical Background

ARA 290 has the chemical formula C44H68N12O12 with a molar mass of 933.1 g/mol. The compound is also known by the following synonyms: ARA 290, ARA290, Erythropoietin-derived peptide, EPO nonapeptide. The structural properties of ARA 290 contribute to its biological activity and research applications, particularly in tissue protection and neuroprotection.

ARA 290 (ARA290) is a synthetic nonapeptide consisting of 9 amino acids derived from the erythropoietin (EPO) molecule. The peptide sequence corresponds to a specific region of EPO that mediates tissue-protective effects without the hematopoietic activity of the full hormone. The compound's structural characteristics allow it to bind to tissue-protective EPO receptor complexes while avoiding the erythropoietic effects associated with full EPO. The synthetic nature of ARA 290 (ARA290) ensures consistent quality and purity for laboratory research applications.

The structural characteristics of ARA 290 (ARA290) allow it to function as a tissue-protective peptide without hematopoietic activity. The compound's ability to activate tissue-protective EPO receptors, provide neuroprotective effects, and reduce inflammation makes it valuable for research into tissue protection, neuroprotection, and anti-inflammatory mechanisms. The peptide's EPO-derived origin and tissue-protective properties make it particularly relevant for research into tissue protection, neuroprotection, and peripheral neuropathy.

## Laboratory Applications

ARA 290 (ARA290) is used in laboratory research to investigate tissue protection and anti-inflammatory mechanisms. Research applications include studies on neuroprotection, tissue repair, inflammatory responses, peripheral neuropathy, and tissue protection pathways in experimental models.

Researchers typically employ ARA 290 (ARA290) in in vitro cell culture studies, ex vivo tissue experiments, and biochemical assays to understand its effects on cellular mechanisms and signaling pathways. The compound's lab-handling relevance is significant, as proper preparation, storage, and administration protocols are essential for obtaining reliable and reproducible research results.

In vitro applications of ARA 290 (ARA290) involve studies conducted in controlled laboratory environments using cell cultures, tissue samples, or isolated biological systems. These studies allow researchers to investigate the compound's effects on specific cellular processes, including:

- **Neuronal cell culture studies**: Investigating effects on neuronal survival, neurite outgrowth, and protection against neurotoxic insults in neuronal cell cultures
- **Peripheral nerve cell research**: Studying effects on peripheral nerve cell survival, function, and regeneration in nerve cell cultures
- **EPO receptor binding assays**: Measuring binding affinity and activation of tissue-protective EPO receptor complexes
- **Tissue protection assays**: Investigating cytoprotective effects on various cell types exposed to injury or stress
- **Anti-inflammatory studies**: Measuring effects on pro-inflammatory and anti-inflammatory cytokine production in cell culture models
- **Cellular survival assays**: Measuring effects on cell viability, apoptosis, and survival pathways
- **Oxidative stress protection studies**: Investigating effects on cellular antioxidant systems, reactive oxygen species levels, and oxidative damage markers
- **Inflammatory signaling pathway studies**: Investigating effects on NF-κB, MAPK, and other inflammatory signaling pathways
- **Tissue repair assays**: Studying effects on cell migration, proliferation, and tissue repair processes in cell culture models
- **Cytokine expression profiling**: Measuring effects on cytokine gene expression and protein production using qPCR, ELISA, or other analytical methods
- **Gene expression profiling**: Investigating effects on gene expression related to tissue protection, neuroprotection, and anti-inflammatory mechanisms using microarray or RNA-seq analysis
- **Signal transduction pathway analysis**: Studying activation of EPO receptor signaling, tissue protection pathways, and other cellular signaling cascades

Ex vivo applications involve experiments conducted on tissues or organs removed from their natural biological environment but maintained in conditions that preserve their biological activity. These studies provide insights into how ARA 290 (ARA290) interacts with intact biological systems while maintaining experimental control. Research applications include:

- **Peripheral nerve tissue studies**: Investigating effects on peripheral nerve function, protection, and regeneration in intact nerve tissue
- **Nervous system tissue research**: Studying effects on nervous system tissue protection and function in intact tissue systems
- **Ischemic injury models**: Investigating protective effects in models of ischemic injury
- **Tissue protection models**: Studying effects on tissue protection and recovery in various tissue types
- **Inflammatory tissue models**: Investigating effects on tissue protection and repair in inflammatory environments

Researchers working with ARA 290 (ARA290) should follow established laboratory protocols, maintain sterile conditions during reconstitution and handling, and adhere to all safety guidelines. Proper documentation of experimental procedures, storage conditions, and handling protocols is essential for research reproducibility and scientific rigor. The compound's role in tissue protection and neuroprotection makes careful handling particularly important for maintaining biological activity and ensuring reliable experimental results.

## Handling and Storage Guidelines

Storage Requirements: Store lyophilized powder at -20°C in a dry environment. Protect from light and moisture. Reconstituted solution should be stored at 4°C for up to 14 days. Maintain sterile conditions during reconstitution.

Handling Guidelines: Handle using sterile techniques and appropriate laboratory personal protective equipment (PPE). Use in well-ventilated areas. Avoid inhalation, ingestion, or skin contact. Follow standard laboratory safety protocols. Refer to Material Safety Data Sheet (MSDS) for complete safety information.

Shelf Life: 36 months when stored properly as lyophilized powder under recommended conditions (-20°C, dry environment, protected from light and moisture).

Reconstitution Notes: When reconstituting ARA 290 (ARA290), use sterile water or appropriate buffer solutions. Maintain sterile conditions throughout the reconstitution process. Store reconstituted solutions at 4°C and use within 14 days. Avoid repeated freeze-thaw cycles, as this may affect peptide stability and biological activity. Protect reconstituted solutions from light exposure.

Temperature Sensitivity: ARA 290 (ARA290) should be stored at -20°C to maintain peptide stability and biological activity. Avoid exposure to higher temperatures that could denature the peptide or reduce its biological activity. When working with the peptide, minimize time at room temperature and return to appropriate storage conditions promptly.

## Cross-Linked Research

Related research peptides in the same category:

- [BPC-157](/blog/bpc-157)
- [KPV](/blog/kpv-10mg)
- [Thymalin](/blog/thymalin-10mg)

## External Citations

Reference authoritative research sources:

- [PubMed Search: ARA 290 Research Literature](https://pubmed.ncbi.nlm.nih.gov/?term=ARA+290) (PubMed (NCBI))
- [PubMed Search: ARA290 Research Literature](https://pubmed.ncbi.nlm.nih.gov/?term=ARA290) (PubMed (NCBI))
- [PubMed Search: Erythropoietin-derived Peptide Research](https://pubmed.ncbi.nlm.nih.gov/?term=erythropoietin-derived+peptide) (PubMed (NCBI))
- [ARA 290 - Chemical Information Database](https://www.ncbi.nlm.nih.gov/) (NCBI)

## References

- PubMed. Search results for "ARA 290" in research literature. National Library of Medicine. https://pubmed.ncbi.nlm.nih.gov/?term=ARA+290
- PubMed. Search results for "ARA290" in research literature. National Library of Medicine. https://pubmed.ncbi.nlm.nih.gov/?term=ARA290
- PubMed. Search results for "erythropoietin-derived peptide" in research literature. National Library of Medicine. https://pubmed.ncbi.nlm.nih.gov/?term=erythropoietin-derived+peptide
- Chemical Formula: C44H68N12O12
- Molar Mass: 933.1 g/mol
- Synonyms: ARA290, Erythropoietin-derived peptide, EPO nonapeptide

---

## Research Use Only Disclaimer

<div className="p-6 bg-red-900/30 border-l-4 border-red-500 rounded">
  <h3 className="text-heading text-lg font-semibold text-red-400 mb-2">
    Research Use Only Disclaimer
  </h3>
  <div className="text-sm text-red-300 whitespace-pre-line">
    All materials are sold strictly for laboratory research use only. Not for human administration.
  </div>
</div>

---

## Related Product

[View ARA 290 Product Page](/products/ara-290-10mg)

